Yongkangmen Health and Drug Chain Store to market and sell China Kangtai Cactus Biotech's products

China Kangtai Cactus Biotech Inc. (OTCBB: CKGT), a vertically integrated grower, developer, manufacturer and marketer of a variety of cactus-based products in China, announced today that it has signed a three-year marketing and sales agreement with Yongkangmen Health and Drug Chain Store Group Ltd. to sell its nutritious and patented cactus-based products, including nutraceuticals, health food, and health and energy drinks.

Yongkangmen Health and Drug Chain Store, headquartered in Beijing City, has controlling ownership in more than 3,000 drugstores throughout China. Additionally, Yongkangmen owns one pharmaceutical manufacturer and three pharmaceutical wholesalers in Hebei Province, and farms Chinese herbal medicine plants on its land in Baekdu Mountain (also known as Changbai Mountain) in Jilin Province. Yongkangmen's business is focused on health products and preventative medicine.

Under the agreement, all the Yongkangmen drugstores nationwide will promote, market and sell China Kangtai's cactus-derived products for the next three years.

China Kangtai CEO Jinjiang Wang said, "Traditional Chinese beliefs view herbal-based medicine and dietary supplements as an alternative to healthcare. The demand for our cactus health products has been expanding every year. By leveraging Yongkangmen's prominence in the health product retail industry, we can expand our market share into new territories exponentially, which creates a win-win situation for both Yongkangmen and Kangtai."